Lachmann H - Search Results

1

Assessment of the Hemophagocytic Lymphohistiocytosis HScore in Patients With Coronavirus Disease 2019.

Clark KEN, Nevin WD, Mahungu T, Lachmann H, Singh A. Clark KEN, et al. Among authors: lachmann h. Clin Infect Dis. 2021 Nov 2;73(9):e3110-e3112. doi: 10.1093/cid/ciaa1463. Clin Infect Dis. 2021. PMID: 32985664 Free PMC article.

2

Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series.

Clark KEN, Collas O, Lachmann H, Singh A, Buckley J, Bhagani S. Clark KEN, et al. Among authors: lachmann h. Rheumatol Adv Pract. 2020 Aug 4;4(2):rkaa040. doi: 10.1093/rap/rkaa040. eCollection 2020. Rheumatol Adv Pract. 2020. PMID: 32964179 Free PMC article.

3

Adult-onset tumour necrosis factor receptor-associated periodic syndrome presenting as transfusion-dependent refractory haemophagocytosis.

Youngstein T, B C Koh M, Ros Soto J, Rowczenio D, Trojer H, Lachmann HJ, Sofat N. Youngstein T, et al. Among authors: lachmann hj. Rheumatology (Oxford). 2018 Mar 1;57(3):582-583. doi: 10.1093/rheumatology/kex427. Rheumatology (Oxford). 2018. PMID: 29228362 No abstract available.

4

The role of immunological assessment in patients with acute kidney injury and possible myeloma.

Lachmann HJ, Wassef NL. Lachmann HJ, et al. Adv Chronic Kidney Dis. 2012 Sep;19(5):287-90. doi: 10.1053/j.ackd.2012.07.002. Adv Chronic Kidney Dis. 2012. PMID: 22920638 Review.

5

Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis.

Benzian-Olsson N, Dand N, Chaloner C, Bata-Csorgo Z, Borroni R, Burden AD, Cooper HL, Cornelius V, Cro S, Dasandi T, Griffiths CEM, Kingo K, Koks S, Lachmann H, McAteer H, Meynell F, Mrowietz U, Parslew R, Patel P, Pink AE, Reynolds NJ, Tanew A, Torz K, Trattner H, Wahie S, Warren RB, Wright A, Barker JN, Navarini AA, Smith CH, Capon F; ERASPEN consortium and the APRICOT and PLUM study team. Benzian-Olsson N, et al. Among authors: lachmann h. JAMA Dermatol. 2020 Nov 1;156(11):1216-1222. doi: 10.1001/jamadermatol.2020.3275. JAMA Dermatol. 2020. PMID: 32936291 Free PMC article.

6

COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologics.

Peet CJ, Papadopoulou C, Sombrito BRM, Wood MR, Lachmann HJ. Peet CJ, et al. Rheumatol Adv Pract. 2021 Aug 23;5(2):rkab043. doi: 10.1093/rap/rkab043. eCollection 2021. Rheumatol Adv Pract. 2021. PMID: 34466775 Free PMC article.

7

Outcome in renal Al amyloidosis after chemotherapy.

Pinney JH, Lachmann HJ, Bansi L, Wechalekar AD, Gilbertson JA, Rowczenio D, Sattianayagam PT, Gibbs SD, Orlandi E, Wassef NL, Bradwell AR, Hawkins PN, Gillmore JD. Pinney JH, et al. Among authors: lachmann hj. J Clin Oncol. 2011 Feb 20;29(6):674-81. doi: 10.1200/JCO.2010.30.5235. Epub 2011 Jan 10. J Clin Oncol. 2011. PMID: 21220614

8

Secondary, AA, Amyloidosis.

Papa R, Lachmann HJ. Papa R, et al. Rheum Dis Clin North Am. 2018 Nov;44(4):585-603. doi: 10.1016/j.rdc.2018.06.004. Epub 2018 Sep 7. Rheum Dis Clin North Am. 2018. PMID: 30274625 Review.

9

A pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement.

Manwani R, Page J, Lane T, Burniston M, Skillen A, Lachmann HJ, Gillmore JD, Fontana M, Whelan C, Hawkins PN, Wagner T, Wechalekar AD. Manwani R, et al. Amyloid. 2018 Dec;25(4):247-252. doi: 10.1080/13506129.2018.1552852. Epub 2019 Jan 19. Amyloid. 2018. PMID: 30661419

10

Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review.

Tufan A, Lachmann HJ. Tufan A, et al. Turk J Med Sci. 2020 Nov 3;50(SI-2):1591-1610. doi: 10.3906/sag-2008-11. Turk J Med Sci. 2020. PMID: 32806879 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

373 results

Search Page